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Abstract
Background—Approximately 1 in 2000 infants is born with a limb deficiency in the US. 
Research has shown that women’s periconceptional diet and use of vitamin supplements can affect 
risk of birth defects. We investigated whether maternal consumption of nutritional antioxidants 
was associated with occurrence of transverse (TLD) and longitudinal limb deficiencies (LLD).
Methods—We analysed case-control data from mothers and their singleton infants with TLD 
(n=566), LLD (n=339), or no malformation (controls; n=9384) in the National Birth Defects 
Prevention Study (1997–2009). Using a modified food frequency, we estimated usual pre-
pregnancy antioxidant consumption by total fruit and vegetable consumption (in grams) grouped 
into tertiles, and cumulative antioxidant score (ranging from 1–10) based on consumption of three 
antioxidants: beta-carotene, lycopene, and lutein. We estimated odds ratios (OR) adjusted for 
maternal age, race/ethnicity, education, smoking, alcohol use, body mass index, and total energy.
Results—Compared to women in the lowest tertile of fruit and vegetable consumption, women in 
the highest tertile were less likely to have infants with TLD (OR 0.74, 95% CI 0.57, 0.96) or LLD 
(OR 0.82, 95% CI 0.59, 1.13). Compared to the lowest antioxidant consumption score of 1, those 
with the highest score of 10 had ORs of 0.68 (95% CI 0.48, 0.95) for TLD and 0.77 (95% CI 0.50, 
1.17) for LLD.
Conclusions—Dietary intake of antioxidants was associated with reduced odds of limb 
deficiencies. These findings add further evidence for women’s periconceptional diet reducing 
occurrence of some birth defects.
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Introduction
Congenital limb deficiencies, defined as either partially formed or completely absent 
limb(s), are present in approximately 1 in 2000 infants at birth.1,2 Limb deficiencies 
primarily originate during embryonic development early in the first trimester of pregnancy; 
at approximately 26 days of gestation, limb formation begins and continues through week 
eight.3 The majority of limb deficiencies can be categorised as transverse limb deficiency 
(TLD) or longitudinal limb deficiency (LLD). TLD refers to a limb that has developed 
normally up to a particular point but beyond which no skeletal elements exist (e.g. arm with 
normal development from the shoulder up to the elbow with the arm ending in a bud at the 
elbow). LLD refers to a reduction or absence of bone in or along the length of the limb. In 
LLD there may be normal skeletal elements beyond the affected area (e.g. leg missing 
fibula). Single-gene mutations, chromosomal anomalies, and exposure to teratogenic drugs 
account for far fewer than half of all limb deficiencies.4 The mechanism by which the 
majority of other limb deficiencies result remains poorly understood.
Though maternal diet is known to play a key role in fetal development,5 the impact of 
overall maternal diet on the risk of congenital limb deficiencies specifically has not been 
investigated. However, a number of studies have examined whether folic acid, multivitamin 
supplementation, or individual nutrients may reduce the risk of limb deficiencies and some, 
but not all, studies have found a pattern of lower risk.2,6,7
In addition to overall healthy diet and specific nutrients like folic acid, antioxidants may be 
an important dietary component to consider in preventing congenital anomalies. 
Antioxidants act to reduce oxidative stress by inhibiting the formation of reactive oxygen 
species (ROS) or reducing the number of free radicals formed, thereby possibly preventing 
some congenital anomalies caused by this mechanism as it relates to both cell proliferation 
and apoptosis during embryogenesis.8–10
The relation between dietary antioxidant intake and limb deficiencies has not been 
investigated. The objective of this study was to investigate whether maternal antioxidant 
consumption is associated with occurrence of TLD or LLD.
Methods
We conducted an analysis using data from the National Birth Defects Prevention Study 
(NBDPS), a multi-state, population-based, case-control study of more than 30 major 
structural birth defects. Details of the NBDPS design and data collection protocol are 
published.11 Briefly, population-based surveillance programs in each participating state 
(Arkansas, California, Georgia, Iowa, Massachusetts, North Carolina, New Jersey, New 
York, Texas, and Utah) were used to identify eligible cases of birth defects as well as live-
born infants without a birth defect (controls). Cases were live births, stillbirths, or induced 
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abortions; controls were live births only, sampled using birth certificates or hospital records 
to represent the base population from which the cases arose. In this analysis, we included 
cases and controls with an estimated date of delivery between October 1997 and December 
2009.
Maternal interviews were conducted via telephone using a standardised computer-assisted 
interview available in either English or Spanish. The interview collected socio-demographic, 
clinical, and dietary information among other things by maternal recall. Interviews were 
administered after 6 weeks or more had passed since the infant’s estimated date of delivery 
(EDD) and no later than 2 years after the EDD. Participation was similar among cases (67%) 
and controls (65%) in NBDPS.11 The median time since EDD to interview was 10 months 
for TLD, 11 months for LLD, and 8 months for controls.
Case Classification
Cases of limb deficiencies identified by each center were reviewed for eligibility by clinical 
geneticists at each center, and then their mothers were recruited to participate in the NBDPS 
interview. A secondary review of all cases across all centers was undertaken to 
systematically classify cases of TLD and LLD; each case was further specified as having an 
isolated defect (1 major limb deficiency), multiple (≥2 major yet unrelated birth defects of 
which at least one was a limb deficiency), or complex (≥2 major birth defects which are 
suspected to be related of which at least one was a limb deficiency).12 Further, cases with 
chromosomal abnormalities or with recognised or strongly suspected single-gene disorders 
or syndromes were excluded. Eligible cases had the following British Pediatric Association 
diagnostic codes: TLD (755.200–209, 755.240–249, 755.300–309, 755.340–349) and LLD 
(755.250–279, 755.350–379) (see Table S1 for a complete list of eligible limb deficiencies). 
In fifteen cases, TLD and LLD were present concurrently and as such these cases were 
included in the analyses for TLD and again for LLD.
Exposure Assessment
As part of the maternal interview, a modified 63-item Willet food frequency questionnaire 
(FFQ) was administered to collect information on maternal diet in the year before 
pregnancy.13 Response options included 16 levels of frequency ranging from “never” to “6 
or more [servings] per day”. Additional questions assessed consumption of cereals, soda, 
coffee, and tea. Quantity of each food consumed per day was calculated as average 
grams/day based on standard portion sizes. Nutrient intakes were calculated using the US 
Department of Agriculture (USDA) nutrient database, version 25.14 Calculated values for 
specific nutrient intake were based on foods consumed and did not consider intake of the 
nutrient from either vitamin supplements or food supplements (e.g. meal replacement shake, 
protein bar).
Maternal antioxidant consumption was assessed using two independent methods, which 
examine antioxidant intake at the level of major food groups (Method 1) as well as 
individual nutrients (Method 2).
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Method 1, Total Fruits and Vegetables—Fruit and vegetables are the major source of 
antioxidants in our daily diet.15 We calculated total fruit and vegetables consumption by 
summing estimated grams per day consumed for the 21 fruit and vegetable FFQ items. We 
created tertiles of consumption of total fruits and vegetables (high/med/low) based on the 
distribution among eligible controls. In analyses, the lowest tertile was the reference 
category.
Method 2, Cumulative Antioxidant Score—To estimate an antioxidant score, we 
selected three key antioxidants, beta-carotene, lycopene, and lutein, based on their 
prominent consumption in an average diet and potential for accurate estimation. We 
calculated an antioxidant score based on consumption of these three nutrients with the 
following steps: (1) We summed estimated nutrient consumption per day across all food 
items for each of the three antioxidants; (2) Based on the distribution of the three 
antioxidants in controls, we created cut-points for quartiles of consumption. Each participant 
received a score based on their quartile of consumption for each antioxidant (1st – 4th 
quartile (lowest to highest) are scored 0, 1, 2, 3 respectively); (3) The score for each 
antioxidant (minimum score of 0, maximum score of 3) is summed across the three 
nutrients, resulting in a cumulative antioxidant score. This score (+1 to facilitate statistical 
modeling) was then assigned to each study participant (cumulative minimum score of 1, 
cumulative maximum score of 10). In analyses, we treated cumulative antioxidant score as a 
continuous variable.
Statistical Analysis
To estimate the association between antioxidant consumption and limb deficiencies, we fit 
separate unconditional logistic regression models for TLD and LLD to estimate odds ratios 
(ORs) and 95% confidence intervals (CIs) for each method: with antioxidant consumption 
categorised in tertiles of total grams of fruits and vegetables (Method 1), and then for 
cumulative antioxidant score (Method 2). The following variables, selected a priori based on 
subject matter expertise and use of causal directed acyclic graphs (Figure S1),16 were 
included in adjusted models to control for confounding: maternal age (continuous, squared), 
maternal race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, other), maternal 
education (≤high school or >high school), pre-pregnancy body mass index (BMI) (four 
categories: underweight, normal, overweight, obese),17 smoking (any or none while 
pregnant), and alcohol use (any or none 1 month prior to pregnancy through the first 
trimester). We also adjusted for total energy intake.18 Additionally, we explored possible 
effect measure modification and confounding by folic acid-containing supplement use (any 
or none) anytime from 1 month prior to pregnancy through the second month of pregnancy. 
Covariate information was obtained during the interview. Effect measure modification was 
evaluated for statistical significance of the interaction terms and through visual inspection of 
a graph plotting antioxidant consumption and the odds ratio of limb deficiency by folic acid 
use.
To assess model fit by the form of the exposure variable, we allowed for flexibility in 
modeling the cumulative antioxidant score (i.e. quadratic, cubic, and categorical treatment of 
the cumulative antioxidant score). The same was done for total fruit and vegetable 
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consumption (i.e. continuous, quadratic, quartiles of consumption). We also included other 
antioxidants (Vitamin C and Vitamin E), a pro-oxidant (iron), and folic acid supplementation 
when assessing model fit to see if these additional nutrients could further explain the 
exposure-outcome relation. If strong attenuation of exposure-outcome relation occurred 
when adding these nutrients to the model, collinearity would be present.
Our analysis included 890 cases (81% of available cases) and 9,384 controls (91%) after 
applying the following exclusion criteria: (1) limb deficiency other than transverse or 
longitudinal (n=56); (2) multiple/unknown number of babies (n=394); (3) pre-pregnancy 
Type I or Type II diabetes (n=91); (4) folate antagonist medication use (n=101); (5) first-
degree family history of limb deficiencies (n=33); (6) extreme or out-of-range caloric intake 
(<1st or >99th percentile, based on controls) (n=378); (7) more than one missing food item 
on the FFQ (n=222). Among the 566 cases of TLD and 339 cases of LLD included in the 
analysis, approximately 73% were cases of isolated limb deficiencies, and the majority were 
livebirths (95%).
Results
In our first approach to capturing antioxidant consumption, we determined tertiles (high, 
medium, low) of fruit and vegetable consumption. The lowest tertile consumed less than 342 
grams per day of fruits and vegetables, while those in the highest tertile consumed more than 
567 grams per day (see Table 1: Method 1). The shape of the distributions of total gram for 
fruit and vegetable consumption and the three antioxidants were similar among cases and 
controls (further details in Table S2). Our second approach created quartiles of estimated 
nutrient intake for the three key antioxidants with scores based on the quartiles with 
cumulative antioxidant score ranging from 1 to 10. The different nutrients had slightly 
different distributions, and all were reported in micrograms (further details in Table 1: 
Method 2).
Control and case mothers had similar distributions of age, BMI, use of folic acid 
supplementation, and caloric intake (Table 2). Hispanics were more represented among 
cases while Non-Hispanic white mothers were more represented among controls. Control 
mothers had slightly higher education attainment: 58.6% attended college compared to 
55.2% among case mothers. Also, 18.0% of control mothers smoked sometime during 
pregnancy compared to 20.1% of case mothers. Control mothers had slightly elevated 
alcohol consumption (36.6%) compared to case mothers (33.6%). There was some variation 
by center in the distribution of cases and controls. Live births, stillbirths (fetal deaths ≥20 
weeks’ gestation), and infants delivered as result of an induced abortion made up 95.3%, 
1.9%, and 2.8% of limb deficiency cases, respectively.
Results for Method 1
Maternal consumption in the highest tertile of fruit and vegetable consumption was 
associated with an approximately 27% (95% confidence Interval (CI): 5, 44) reduced odds 
of having children born with TLDs compared to mothers who were in the lowest tertile of 
fruit and vegetable consumption over the study period after adjustment for potential 
confounding. The highest tertile compared to the lowest tertile was associated with an 
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approximately 17% (95% CI −14, 40) reduced odds of having a child born with LLD. The 
observed association was stronger in magnitude for the highest tertile than for the middle 
tertile, indicating a possible dose-response, but confidence intervals overlapped considerably 
(see Table 3). No meaningful difference in the association was observed when isolated and 
non-isolated defects were considered separately for either TLD or LLD.
Results for Method 2
Using the cumulative antioxidant score, we analysed the relation between antioxidant 
consumption in the year before pregnancy and the risk of limb deficiencies. We assumed a 
linear relation of cumulative antioxidant score with odds of limb deficiency. To test this 
assumption, we tried more flexible forms of the exposure variable (e.g. quadratic, higher 
order polynomials, categories) all of which resulted in no measureable improvement of 
model fit. Thus, Figure 1 presents the graphical depiction of the linear relation between the 
odds of TLD or LLD and antioxidant consumption as measures by cumulative antioxidant 
score. Increased consumption of antioxidants is associated with reduced odds of both types 
of limb deficiencies.
Mothers with the highest antioxidant score of 10 had an approximately 33% (95% CI: 6–
47%) reduced odds of having a pregnancy affected by TLD compared to mothers with a 
lowest score of 1 (Table 4). Mothers with the highest score of 10 had an approximately 27% 
(95% CI: −13–52%) reduced odds of having a pregnancy affected by LLD compared to 
mothers with a lowest score of 1. Mothers with a score of 10 (6.7% of cases and 7.2% of 
controls) were in the highest quartiles consumption for beta-carotene, lycopene, and lutein/
zeaxanthin consumption. Mothers with a score of 1 (9.6% of cases and 7.5% of controls) 
were in the lowest quartile of consumption for all 3 antioxidants. A similar pattern of 
decreased odds of TLD and LLD with increased antioxidant consumption is seen, for non-
isolated, and isolated deficiency categories, although precision was reduced with these 
smaller sample sizes (Table 4).
Periconceptional folic acid supplementation (FA) did not appear to significantly modify the 
effect of high antioxidant consumption in these data (Likelihood Ratio Test: p>0.05). 
Adjusting for potential confounding by FA did not alter the exposure-outcome relation 
previously indicated (Table S3). Neither adjustment for FA as a potential confounder nor 
treatment of FA as a potential effect modifier changed the observed results for fruit and 
vegetable consumption or cumulative antioxidant score.
Comment
Main findings
Higher intake of antioxidants in the maternal diet – assessed by two methods – was 
associated with a reduced odds of congenital limb deficiencies. This association tended to be 
stronger for transverse than longitudinal limb deficiencies.
When considering antioxidants, there are a wide variety of nutrients that have antioxidant 
properties. Some antioxidants have been consistently associated with better health outcomes 
(i.e. cancer prevention, cardiovascular health) while others have not.19 The largest source of 
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antioxidants in the average American adult diet is coffee and tea. A prior analysis of NBDPS 
data found no convincing evidence of coffee and tea being related to risk of selected birth 
defects (not including limb deficiency) when considering their contribution to maternal 
intake of caffeine.20 This study did not to concentrate on these forms of antioxidants (i.e. 
flavonoids and other polyphenols) as they have not been associated with risk of birth defects.
20
 Further, mothers tend to decrease their consumption of these beverages, during pregnancy.
21
 Instead it focused on food groups that contribute to antioxidant intake (fruits and 
vegetables) and three specific antioxidants (beta-carotene, lycopene, and lutein).
The mechanism by which antioxidants might decrease the risk for limb deficiency and 
particularly for TLD is unknown. One pathway by which antioxidants might decrease risk is 
the reduction of ROS. ROS overproduction often leads to a deleterious process, called 
oxidative stress, which can cause damage to cell structures (i.e. lipids and membranes, 
proteins, and DNA)8. With limb deficiencies in particular, oxidative stress can lead to 
damaged cells causing a reduction in cell proliferation and interfering with cell signaling 
pathways. Consequently abnormal limb formation may occur in the developing embryo and 
fetus such as a shortened limb (e.g. leg ending at the knee). ROS have been associated with 
many negative health outcomes such as teratogenesis10 (including limb deficiency),22 
carcinogenesis23, cardiovascular disease, and neurogenerative diseases.8,24
Interpretation of the findings
In comparing high to low tertiles of fruit and vegetable consumption, women in the highest 
tertile were less likely to have an infant with TLD. From a public health messaging 
perspective, the difference in grams between the lowest and highest tertile of consumption is 
similar to 2 to 3 servings (0.7 to 1.0 cup equivalents). The U.S. Food Patterns corresponding 
to the 2010 U.S. Dietary Guidelines31 recommends consuming daily 2 cups of fruits and 2.5 
cups of vegetables (based on a 2,000 calorie diet). A mother who consumed the daily 
recommended intake of fruits and vegetables31 would be around the cut-point for the high 
and medium tertile. These results support existing fruit and vegetable consumption 
recommendations.31 The relation observed suggests, should a causal relation exist, an 
increase of approximately 2.5 additional servings per day among low fruit and vegetable 
consuming moms could have a population-level impact on the prevalence of congenital limb 
deficiencies.
Limitations of the data
This study had some limitations. First, the FFQ used to determine antioxidant exposure 
asked about average food intake during the year before pregnancy, and while most diets 
remain very similar during pregnancy,25–27 it is not known if this is the case in this study 
sample. That said, it is unlikely for usual diet to change substantially in the first few weeks 
of pregnancy, before pregnancy recognition and before nausea and vomiting which may then 
lead to some changes in diet. Further the diet prior to pregnancy itself is important to 
consider as foods eaten in the months prior to conception would impact the nutritional stores 
used during pregnancy. Second, the self-reported nature of the questionnaire may lead to 
potential bias of effect estimation by two means (1) non-differential misclassification of diet 
due to the difficulty in accurately recalling a distant past behavior (e.g. >1.5 years 
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previously) and (2) differential misclassification of diet by case versus control status. The 
direction of the latter form of misclassification cannot be determined with the data available 
and could, in this study, either attenuate (e.g. a mother with an infant born with a limb 
deficiency might be hesitant to recall a less than health diet) or intensify (e.g. said mother 
might be more critical of her own diet and thereby recall a poorer diet compared to a control 
mother) the magnitude of the estimates. Was the differential misclassification to bias 
estimates away from the null, it is unlikely the misclassification would explain the observed 
associations and trends in their entirety. Lastly, while a significant association is detected at 
the level of food groups and cumulative antioxidant score, one cannot separate out the effect 
of a dietary pattern that is high in antioxidants from the antioxidants themselves.
That said, findings remained consistent in several sensitivity analyses in models that 
included other antioxidants (Vitamin C and Vitamin E), a pro-oxidant (iron), and allowed for 
flexibility of exposure modelling, demonstrating stability of the exposure-outcome relation 
(data not shown). Further, the reduced risk of observed with antioxidants was not diminished 
when FA supplementation was included in models as a covariate. In post-hoc analyses that 
included FA supplementation as a covariate there was no change in the magnitude of the 
association, but the precision of the estimates improved suggesting that FA supplementation 
may only being associated with the outcome not antioxidant intake.28
Supplemental forms of beta-carotene, lycopene, and lutein were not included in nutrient 
consumption estimates. While beta-carotene is present in many multivitamins, lycopene and 
lutein are not typically found in multivitamins and are not common supplements. If 
supplementation had an effect on the odds of limb deficiency, it is anticipated that this would 
have diluted the odds ratio estimates.
Strengths of the study
There are several strengths of this study. Extensive surveillance paired with a thorough 
questionnaire in the NBDPS allowed for maternal diet to be examined in relation to the risk 
of a rare birth defect, congenital limb deficiencies. Second, the representative nature of the 
study due to population-based sampling and 10 states contributing data increases confidence 
in generalising results for multiple regions of the United States. Indeed, Cogswell et al. 
found that NBDPS controls were representative of their base populations in many ways.29 
Further, the geographic, temporal, and demographic diversity of the NBDPS sample captures 
a large degree of variability in diet, allowing for assessment of a wider range of antioxidant 
exposure. Third, the limb deficiency case definition was based on strict inclusion/exclusion 
criteria and systematic classification. Individual case review by a single clinical geneticist 
limits the potential for outcome misclassification. Fourth, the etiologies of transverse limb 
deficiencies (TLD) and longitudinal limb deficiencies (LLD) are suspected to be different,
6,30
 and the NBDPS provided sufficient sample size to examine each phenotype individually.
Conclusions
Findings from this study indicate that higher maternal intake of fruits and vegetables and 
higher intake of antioxidants in the diet in the year before pregnancy are associated with a 
reduced odds of congenital limb deficiencies, particularly TLD, in offspring. These findings 
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add further evidence to the importance of the quality of a women’s periconceptional diet in 
reducing the occurrence of some birth defects. The literature on maternal nutrition and birth 
defects would benefit from a detailed examination of the role of antioxidants in relation to 
other birth defects including rarer forms of limb deficiencies (i.e. intercalary deficiencies) 
not examined here. Further investigation of causal mechanisms by which antioxidants may 
act as protective agents in birth defect etiologies is needed. Replication of this research in 
other studies to examine consistency of results is recommended.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 2
Demographic Characteristics of Cases of Congenital Limb Deficiency and Controls in the National Birth 
Defects Prevention Study, 1997–2009.
Maternal Characteristic
Cases
No. (%)/Mean (sd) (N=890)
Controls
No. (%)/Mean (sd) (N=9384)
Age at conception, yr 26.5 (6.0) 26.9 (6.0)
 min, max 13, 45 13, 49
Race/ethnicity
 Non-Hispanic White 491 (55.2) 5489 (58.5)
 Non-Hispanic Black 89 (10.0) 1012 (10.8)
 Hispanic 257 (28.9) 2210 (23.6)
 Other 53 (6.0) 667 (7.1)
 Missing 0 (0.0) 6 (0.1)
Education
 ≤ High school 391 (43.9) 3827 (40.8)
 > High school 491 (55.2) 5499 (58.6)
 Missing 8 (0.9) 53 (0.6)
Prepregnancy Body Mass Index
 Underweight (<18.5) 44 (4.9) 490 (5.2)
 Normal (≥18.5, <25) 441 (49.6) 4880 (52.0)
 Overweight (≥25, <30) 203 (22.8) 2060 (22.0)
 Obese (≥30) 158 (17.8) 1560 (16.6)
 Missing 44 (4.9) 394 (4.2)
Alcohola
 Yes 299 (33.6) 3437 (36.6)
 No 583 (65.5) 5885 (62.7)
 Missing 8 (0.9) 62 (0.7)
Smokeb
 Yes 179 (20.1) 1685 (18.0)
 No 704 (79.1) 7672 (81.8)
 Missing 7 (0.8) 27 (0.3)
Folic Acid Supplementationc
 Yes 666 (74.8) 7015 (74.8)
 No 224 (25.2) 2368 (25.2)
 Missing 0 (0.0) 1 (0.0)
Energy, kcal 1661.2 (711.6) 1669.1 (698.5)
 min, max 535.9, 4694.9 502.7, 4898.8
a
Drinking alcohol anytime between 1 month before pregnancy through the first trimester
bAnytime during pregnancy
c
Folic acid supplementation anytime from 1 month prior to pregnancy through the second month of pregnancy
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